Description Indication Afabeta is indicated for the treatment of chloroquine-resistant Plasmodium falciparum malaria and cerebral malaria. Dosage Afabeta is administered via intramuscular injection. The typical dosage is: Adults: 150 mg (2 ml) once daily for three consecutive days. Children: Dosage is adjusted based on body weight, typically 3 mg/kg body weight once daily for three consecutive days. Side Effects Afabeta is generally well-tolerated, but some mild side effects may include: Nausea Dizziness Tinnitus (ringing in the ears) Precautions Hypersensitivity: Contraindicated in patients with known hypersensitivity to artemisinin derivatives. Pregnancy: Use with caution during pregnancy.
